Beech Biotech is developing a novel treatment for preeclampsia, an severe unmet medical need that takes the lives of 70,000 women and 500,000 babies each year. The company is developing a novel placenta-impermeable antibody and works with a network of expert industry consultants and contractors.

Location
Canton
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2022
  • Number of employees in Switzerland
    1-9
Key business

You may also be interested in